Morgan Stanley analyst Cecilia Furlong maintains TransMedics Group (NASDAQ:TMDX) with a Equal-Weight and raises the price target from $54 to $63.
Analyst Expects This Alcohol Stock To Show ‘The Fighting Spirit’ During The Economic Downturn
Questions about whether beer and alcohol consumption would remain steady during a recession have risen recently as worries about an imminent recession have grown.
